Edge-to-face CH/π interaction between ligand Phe-phenyl and receptor aromatic group in the thrombin receptor activation

被引:23
作者
Matsushima, A
Fujita, T
Nose, T
Shimohigashi, Y [1 ]
机构
[1] Kyushu Univ, Fac Sci, Dept Chem, Lab Struct Funct Biochem, Fukuoka 8128581, Japan
[2] Kyushu Univ, Fac Sci, Grad Sch Sci, Fukuoka 8128581, Japan
关键词
CH/pi interaction; fluorophenylalanine; phenylalanine; thrombin receptor;
D O I
10.1093/oxfordjournals.jbchem.a022745
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the ligand/receptor interaction, the side chain phenyl group of phenylalanine (Phe) is involved in a so-called hydrophobic interaction, in which the]Phe-phenyl group functions as a pi element or merely as a hydrophobic element. The thrombin receptor-tethered ligand SFLLRNP consists of the Phe-2 residue essential for receptor activation, In order to explore the molecular characteristics of this Phe-2-phenyl group, a complete set of S/Phe/LLRNP peptides comprising six different difluorophenylalanine isomers [(F-2)Phe] was newly synthesized and assayed to evaluate their ability to induce the aggregation of human platelets, The assay results clarified several important structural elements to conclude that Phe-2-phenyl of S/Phe/LLRNP is in the edge-to-face CH/pi Interaction with the receptor aromatic group, utilizing the Phe-phenyl edge along with adjacent benzene hydrogens at positions (2-3) or (5-6). It was also found that the fluorine atom at position 4 increases the acidity of the hydrogen mainly at its ortho position, resulting in a reinforcement; of the CH/pi interaction and thus in an enhancement of biological activity. The H-->F replacement in the benzene ring was found to provide an effective structural examination to the Phe residue; i.e., to identify the hydrogens in the CH/pi interaction, and to strengthen the CH/pi interaction.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 29 条
  • [1] Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor
    Ahn, HS
    Foster, C
    Boykow, G
    Arik, L
    SmithTorhan, A
    Hesk, D
    Chatterjee, M
    [J]. MOLECULAR PHARMACOLOGY, 1997, 51 (02) : 350 - 356
  • [2] Development of potent thrombin receptor antagonist peptides
    Bernatowicz, MS
    Klimas, CE
    Hartl, KS
    Peluso, M
    Allegretto, NJ
    Seiler, SM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) : 4879 - 4887
  • [3] ESSENTIAL GROUPS IN SYNTHETIC AGONIST PEPTIDES FOR ACTIVATION OF THE PLATELET THROMBIN RECEPTOR
    CHAO, BH
    KALKUNTE, S
    MARAGANORE, JM
    STONE, SR
    [J]. BIOCHEMISTRY, 1992, 31 (27) : 6175 - 6178
  • [4] Benzene dimer: A good model for pi-pi interactions in proteins? A comparison between the benzene and the toluene dimers in the cas phase and in an aqueous solution
    Chipot, C
    Jaffe, R
    Maigret, B
    Pearlman, DA
    Kollman, PA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (45) : 11217 - 11224
  • [5] Cation-pi interactions in chemistry and biology: A new view of benzene, Phe, Tyr, and Trp
    Dougherty, DA
    [J]. SCIENCE, 1996, 271 (5246) : 163 - 168
  • [6] DEVELOPMENT OF A POTENT THROMBIN RECEPTOR-LIGAND
    FENG, DM
    VEBER, DF
    CONNOLLY, TM
    CONDRA, C
    TANG, MJ
    NUTT, RF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (20) : 4125 - 4130
  • [7] Frisch M.J., 1995, GAUSSIAN 94
  • [8] Synthesis of a complete set of L-difluorophenylalanines, L-(F2)Phe, as molecular explorers for the CH/-π interaction between peptide ligand and receptor
    Fujita, T
    Nose, T
    Matsushima, A
    Okada, K
    Asai, D
    Yamauchi, Y
    Shirasu, N
    Honda, T
    Shigehiro, D
    Shimohigashi, Y
    [J]. TETRAHEDRON LETTERS, 2000, 41 (06) : 923 - 927
  • [9] Importance of the aromatic residue at position 6 of [Nle10]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation
    Gembitsky, DS
    Murnin, M
    Ötvös, FL
    Allen, J
    Murphy, RF
    Lovas, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) : 3004 - 3007
  • [10] Hruby VJ, 1997, BIOPOLYMERS, V43, P219, DOI 10.1002/(SICI)1097-0282(1997)43:3<219::AID-BIP3>3.0.CO